Table 3 Relationships of cholesterol efflux capacity with clinical variables, metabolic syndrome (MetS) components, apolipoproteins (apos) and low-grade inflammation score in 552 subjects according to glucose metabolism status (normal glucose metabolism [NGM], impaired glucose metabolism [IGM] and Type 2 diabetes mellitus [T2DM]) and MetS classification.

From: Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

 

All subjects (n = 552)

NGM (n = 288)

IGM (n = 126)

T2DM (n = 138)

no MetS (n = 255)

MetS (n = 297)

Age

0.035

0.088

−0.063

0.101

0.038

0.069

Systolic blood pressure

0.024

0.082

−0.067

0.106

0.049

0.0.95

Alcohol consumption

0.129**

0.008

0.268**

0.178*

0.034

0.191**

Waist circumference

−0.034

−0.007

−0.033

−0.010

0.026

0.077

Glucose

−0.014

−0.075

0.039

0.100

0.046

0.062

HbA1c

−0.040

−0.030

−0.094

0.013

0.050

−0.010

Non-HDL cholesterol

0.026

0.016

0.003

0.053

0.041

0.095

HDL cholesterol

0.367***

0.372***

0.420***

0.301***

0.365***

0.317***

Triglycerides

−0.048

−0.056

−0.122

0.032

−0.023

0.096

ApoA-I

0.382***

0.365***

0.378***

0.401***

0.339***

0.368***

ApoB

−0.017

−0.034

−0.045

0.035

0.011

0.037

Low-grade inflammation score

−0.125**

−0.075

−0.139

−0.187*

0.009

−0.162**

  1. Sex-adjusted partial correlation coefficients are shown. Apo, apolipopotein; HDL, high density lipoproteins; HbA1c, glycated hemoglobin. Inflammation markers were available in 547 subjects. Triglycerides are log transformed. *P < 0.05; **P ≤ 0.01; ***P ≤ 0.001.
Back to article page